| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1029737057 |
| P356 | DOI | 10.1186/S40170-016-0147-7 |
| P932 | PMC publication ID | 4822279 |
| P698 | PubMed publication ID | 27054036 |
| P5875 | ResearchGate publication ID | 299371913 |
| P50 | author | Varinder Kaur | Q56930908 |
| Thomas Kieber-Emmons | Q104746187 | ||
| P2093 | author name string | Behjatolah Monzavi-Karbassi | |
| Eric R Siegel | |||
| Barbara J Fuhrman | |||
| Fariba Jousheghany | |||
| Laura F Hutchins | |||
| A Mazin Safar | |||
| Srikanth Medarametla | |||
| Rhonda Gentry | |||
| P2860 | cites work | Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: curses, caveats, cautions | Q30817597 |
| Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression | Q33688576 | ||
| Performance of recommended screening tests for undiagnosed diabetes and dysglycemia | Q33955678 | ||
| Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. | Q34662845 | ||
| Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer | Q34662865 | ||
| Risks of Breast and Endometrial Cancer in Women with Diabetes: A Population-Based Cohort Study. | Q34797196 | ||
| The impact of treatment noncompliance on mortality in people with type 2 diabetes | Q35976392 | ||
| The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project | Q36060158 | ||
| Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2. | Q36572819 | ||
| Age, BMI, and race are less important than random plasma glucose in identifying risk of glucose intolerance: the Screening for Impaired Glucose Tolerance Study (SIGT 5). | Q36936991 | ||
| Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women | Q37090766 | ||
| Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer | Q37171293 | ||
| Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. | Q37905773 | ||
| Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis | Q38057630 | ||
| Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature | Q38226775 | ||
| Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure. | Q43091072 | ||
| Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. Direct and potentiating influence | Q43704248 | ||
| Mortality from site-specific malignancies in type 2 diabetic patients from Verona | Q44268211 | ||
| Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort | Q44281903 | ||
| Abnormal glucose tolerance and the risk of cancer death in the United States | Q44471360 | ||
| Incidences of diabetes and prediabetes among female adult breast cancer patients after systemic treatment | Q45111043 | ||
| Glucose intolerance during adjuvant chemotherapy for breast cancer | Q46076207 | ||
| Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin | Q46917157 | ||
| Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer? | Q47215902 | ||
| Diabetes mellitus and breast cancer: a retrospective population-based cohort study. | Q50778799 | ||
| Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. | Q51545574 | ||
| Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. | Q53558619 | ||
| Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients. | Q54570063 | ||
| Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment | Q57734588 | ||
| The impact of diabetes on survival following breast cancer | Q60595423 | ||
| Increased prevalence of prior breast cancer in women with newly diagnosed diabetes | Q60595426 | ||
| Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults | Q64133523 | ||
| Screening mammogram utilization in women with diabetes | Q77292252 | ||
| Increasing Black:White disparities in breast cancer mortality in the 50 largest cities in the United States | Q87410364 | ||
| P304 | page(s) | 7 | |
| P577 | publication date | 2016-04-06 | |
| P1433 | published in | Cancer & Metabolism | Q27724831 |
| P1476 | title | Pre-diagnosis blood glucose and prognosis in women with breast cancer | |
| P478 | volume | 4 |
| Q34558255 | Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation. |
| Q55347754 | Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation. |
| Q48385511 | Corticosteroids compromise survival in glioblastoma in part through their elevation of blood glucose levels. |
| Q90226833 | Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality |
| Q93345911 | Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype |
| Q92617613 | p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas |
Search more.